News

Survival gains seen with rituximab and mycophenolate in RA lung disease

Publish date: May 9, 2014

 

AT RHEUMATOLOGY 2014

Dr. Kelly had no disclosures.

Pages

Recommended Reading

Surgeon General report links smoking to diseases beyond cancer
MDedge Rheumatology
Trial immunosuppressive therapy benefits outweigh long-term lymphoma risks in IBD
MDedge Rheumatology
Real-world data backs rivaroxaban for postop VTE prevention
MDedge Rheumatology
CVS to discontinue sale of tobacco products
MDedge Rheumatology
CVS takes health care seriously
MDedge Rheumatology
FDA stops sale of four tobacco products
MDedge Rheumatology
CDC sounds alarm on hospital antibiotic use
MDedge Rheumatology
Two definitions of Gulf War illness recommended
MDedge Rheumatology
Evidence-Based Apps: Texting reminders improved pediatric asthma control
MDedge Rheumatology
CDC: Policy changes could prevent 100,000 deaths a year
MDedge Rheumatology